MLYS Q1 2026 Earnings Narrow Beat on Losses as Clinical Pipeline Progress Continues AREN Q1 2026 Earnings EPS Misses Estimates by a Wide Margin FTHM Q4 2025 Earnings EPS Misses Estimates as Losses Widen HHH Q1 2026 Earnings EPS Surges Past Estimates by 73 Amid Solid Operations NMRA Q1 2026 Earnings NarrowerThanExpected Loss and Steady Progress in CNS Pipeline SITM Q1 2026 Earnings EPS Surges Past Estimates with 22 Beat